Literature DB >> 23814683

T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome.

Jun-O Jin1, Qing Yu.   

Abstract

Sjögren's syndrome (SjS) is a systemic autoimmune disease that primarily targets salivary and lacrimal glands. SjS affects 2-4 million people in the US alone and greatly affects the life quality of the afflicted individuals. Autoreactive effector T cells are central executors and orchestrators in the pathogenic processes of SjS by mediating target organ inflammation and destruction and by facilitating B cell responses and autoantibody production. A variety of cytokines that are produced by effector T cells or capable of directly affecting effector T cells are elevated in the target organs and circulations of SjS patients. The recent advancement in the understanding about the functions of these cytokines, achieved by using both human samples and mouse disease models, has generated great insights into the cytokine control of autoimmune responses in the SjS disease setting. In this review, we summarized the recent findings on the expression and functions of cytokines in this disease, with specific focus on those derived from T cells and/or directly affecting T cell responses.

Entities:  

Year:  2013        PMID: 23814683      PMCID: PMC3693555          DOI: 10.4172/2155-9899.S1-009

Source DB:  PubMed          Journal:  J Clin Cell Immunol


  119 in total

1.  Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

Authors:  J M van Woerkom; A A Kruize; M J G Wenting-van Wijk; E Knol; I C Bihari; J W G Jacobs; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

Review 2.  T-bet in disease.

Authors:  Vanja Lazarevic; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

3.  Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.

Authors:  A Nakajima; S Hirose; H Yagita; K Okumura
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

4.  Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.

Authors:  Noriyoshi Ogawa; Li Ping; Li Zhenjun; Yukiko Takada; Susumu Sugai
Journal:  Arthritis Rheum       Date:  2002-10

5.  A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Authors:  S Cha; J Brayer; J Gao; V Brown; S Killedar; U Yasunari; A B Peck
Journal:  Scand J Immunol       Date:  2004-12       Impact factor: 3.487

Review 6.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

Review 7.  Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

Review 8.  The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).

Authors:  Amy M Beebe; Daniel J Cua; Rene de Waal Malefyt
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

Review 9.  Stress as a trigger of autoimmune disease.

Authors:  Ljudmila Stojanovich; Dragomir Marisavljevich
Journal:  Autoimmun Rev       Date:  2007-11-29       Impact factor: 9.754

10.  Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.

Authors:  Cuong Q Nguyen; Hongen Yin; Byung Ha Lee; Wendy C Carcamo; John A Chiorini; Ammon B Peck
Journal:  Arthritis Res Ther       Date:  2010-12-23       Impact factor: 5.156

View more
  12 in total

1.  Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.

Authors:  Jing Zhou; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-19       Impact factor: 5.187

2.  Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.

Authors:  Jing Zhou; Xiaofeng Zhang; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-11-12       Impact factor: 5.187

Review 3.  Salivary gland function, development, and regeneration.

Authors:  Alejandro M Chibly; Marit H Aure; Vaishali N Patel; Matthew P Hoffman
Journal:  Physiol Rev       Date:  2022-03-28       Impact factor: 46.500

4.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

5.  Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.

Authors:  Jing Zhou; Bo Ra You; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-11-15       Impact factor: 5.187

6.  CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.

Authors:  Jennifer Y Barr; Xiaofang Wang; David K Meyerholz; Scott M Lieberman
Journal:  Immunol Cell Biol       Date:  2017-05-03       Impact factor: 5.126

7.  Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.

Authors:  Jing Zhou; Toshihisa Kawai; Qing Yu
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

Review 8.  Insight into Salivary Gland Aquaporins.

Authors:  Claudia D'Agostino; Osama A Elkashty; Clara Chivasso; Jason Perret; Simon D Tran; Christine Delporte
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

Review 9.  MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.

Authors:  M Reale; C D'Angelo; E Costantini; M Laus; A Moretti; A Croce
Journal:  J Immunol Res       Date:  2018-06-07       Impact factor: 4.818

10.  Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.

Authors:  Jing Zhou; Jun-O Jin; Toshihisa Kawai; Qing Yu
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.